| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 21, 2021 | May 25, 2021 | aTYR PHARMA INC | Director | Sell | 26.3 | -2,500 | -2.12% | ✗ | $10.9K |
| Aug 28, 2020 | Sep 3, 2020 | aTYR PHARMA INC | Director | Sell | 26.3 | -7,360 | -5.87% | ✗ | $29.5K |
| Aug 26, 2020 | Aug 28, 2020 | aTYR PHARMA INC | Director | Sell | 26.3 | -7,640 | -5.74% | ✗ | $31.7K |
| May 31, 2018 | Jun 4, 2018 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -15,000 | -62.79% | ✓ | $1.5M |
| May 21, 2014 | May 23, 2014 | ALNYLAM PHARMACEUTICALS, INC. | Director | Sell | 5.0 | -35,000 | -79.74% | ✓ | $1.9M |
| Jun 12, 2013 | Jun 13, 2013 | Verastem, Inc. | Director | Buy | 82.5 | +23,171 | 1.00% | ✗ | $222.4K |
| Jun 11, 2013 | Jun 12, 2013 | Verastem, Inc. | Director | Buy | 82.5 | +25,000 | 1.10% | ✗ | $230.5K |
| May 13, 2013 | May 15, 2013 | Verastem, Inc. | Director | Buy | 82.5 | +25,000 | 1.11% | ✓ | $243.4K |
| May 1, 2013 | May 3, 2013 | Verastem, Inc. | Director | Buy | 65.0 | +10,000 | 0.45% | ✓ | $96.6K |
| Apr 17, 2013 | Apr 19, 2013 | Verastem, Inc. | Director | Buy | 65.0 | +5,631 | 0.25% | ✗ | $53.5K |
| Dec 18, 2012 | Dec 20, 2012 | Verastem, Inc. | Director | Buy | 61.3 | +6,193 | 0.28% | ✓ | $48.7K |
| Feb 1, 2012 | Feb 3, 2012 | Verastem, Inc. | Director | Buy | 100.0 | +250,000 | 12.60% | ✗ | $2.5M |